Tower Research Capital (TRC)’s Mountain Crest Acquisition Corp. IV Common Stock MCAF Stock Holding History

Tower Research Capital (TRC)’s Portfolio MCAF Stock Details MCAF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-692	Closed	-$6.29K	–	6260
2023 Q4	$6.29K	Buy	+692	New	+$6.61K	﹤0.01%	4761
2023 Q3	–	Sell	-84	Closed	-$883	–	6356
2023 Q2	$883	Hold	84	–	–	﹤0.01%	5525
2023 Q1	$1K	Sell	84 -52	-38%	-$533	﹤0.01%	5677
2022 Q4	$1K	Hold	136	–	–	﹤0.01%	5737
2022 Q3	$1K	Hold	136	–	–	﹤0.01%	5900
2022 Q2	$1K	Sell	136 -100	-42%	-$989	﹤0.01%	5910
2022 Q1	$2K	Sell	236 -116	-33%	-$1.15K	﹤0.01%	5641
2021 Q4	$3K	Hold	352	–	–	﹤0.01%	5525
2021 Q3	$3K	Buy	+352	New	+$3.43K	﹤0.01%	5165

Other funds holding MCAF

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Tower Research Capital (TRC)'s MCAF Position: Q1 2024 in Review

Tower Research Capital (TRC) sold out of Mountain Crest Acquisition Corp. IV Common Stock (MCAF) in Q1 2024, closing a stake of 692 shares — an estimated $6.29K sold.

Tower Research Capital (TRC) first reported a position in MCAF in Q3 2021 and held it in 9 quarters. The position peaked at $6.29K in Q4 2023. 1 fund tracked by Wall St. Rank holds MCAF as of Q1 2024.

Tower Research Capital (TRC) reported no remaining Mountain Crest Acquisition Corp. IV Common Stock position as of Q1 2024 after selling out during the quarter.
Tower Research Capital (TRC) sold 692 Mountain Crest Acquisition Corp. IV Common Stock shares in Q1 2024, an estimated $6.29K.
Tower Research Capital (TRC) first reported a position in Mountain Crest Acquisition Corp. IV Common Stock in Q3 2021 and held it in 9 quarters.
Tower Research Capital (TRC)'s Mountain Crest Acquisition Corp. IV Common Stock position peaked at $6.29K in Q4 2023.
1 fund tracked by Wall St. Rank held Mountain Crest Acquisition Corp. IV Common Stock as of Q1 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2024, filed 15 May 2024.